OT:RR:BSTC:EOE H364275 RPR
Bryan Nese
Mayer Brown LLP
1999 K Street, N.W.
Washington, DC 20006-1101
VIA EMAIL: [email protected]; [email protected];
[email protected]
RE: Ruling Request; U.S. International Trade Commission; Limited Exclusion Order;
Investigation No. 337-TA-1392; Certain Oil Vaporizing Devices, Components Thereof,
and Products Containing the Same
Dear Mr. Nese,
Pursuant to 19 C.F.R. Part 177, the Exclusion Order Enforcement Branch (EOE Branch),
Regulations and Rulings, U.S. Customs and Border Protection (CBP), issues this ruling letter
holding that STIIIZY IP LLC f/k/a STIIIZY, LLC and STIIIZY Inc. d/b/a Shryne Group Inc.
(collectively, STIIIZY or “Ruling Requester”) has met its burden of proof that its “[[ ]]
(All-In One) AIO Device” (“[[ ]]”) is not subject to the limited exclusion order (“1392
LEO”) that the U.S. International Trade Commission (ITC or Commission) issued as a result of
Investigation No. 337-TA-1392 (“the 1392 investigation”) under section 337 of the Tariff Act of
1930, as amended, 19 U.S.C. § 1337.
We further note that determinations of the Commission resulting from the underlying
investigation or a related proceeding under 19 C.F.R. Part 210 are binding authority on CBP and,
in the case of conflict, will by operation of law modify or revoke any contrary CBP ruling or
decision pertaining to section 337 exclusion orders.
This ruling letter is the result of a request for an administrative ruling under 19 C.F.R. Part
177, which was conducted on an inter partes basis. The proceeding involved the two parties with
a direct and demonstrable interest in the question presented by the ruling request: (1) your client,
STIIIZY, the Ruling Requester and a respondent in the 1392 investigation; and (2) PAX Labs, Inc.
(PAX), the patent owner and complainant in the 1392 investigation (collectively, “the parties”).
See, e.g., 19 C.F.R. § 177.1(c).
The parties were asked to clearly identify confidential information, including information
subject to the administrative protective order in the underlying investigation, with [[red brackets]]
in their submissions. See 19 C.F.R. §§ 177.2, 177.8. If there is additional information in this
ruling letter not currently bracketed in red [[ ]] that either party believes constitutes confidential
information, and should be redacted from the published ruling, the parties are asked to contact the
EOE Branch within ten (10) working days of the date of this ruling letter. See, e.g., 19 C.F.R. §
177.8(a)(3).
Please note that disclosure of information related to administrative rulings under 19 C.F.R.
Part 177 is governed by, for example, 6 C.F.R. Part 5, 31 C.F.R. Part 1, 19 C.F.R. Part 103, and 19
C.F.R. § 177.8(a)(3). See, e.g., 19 C.F.R. § 177.10(a). In addition, CBP is guided by the laws
relating to confidentiality and disclosure, such as the Freedom of Information Act (FOIA), as
amended (5 U.S.C. § 552), the Trade Secrets Act (18 U.S.C. § 1905), and the Privacy Act of 1974,
as amended (5 U.S.C. § 552a). A request for confidential treatment of information submitted in
connection with a ruling requested under 19 C.F.R. Part 177 faces a strong presumption in favor
of disclosure. See, e.g., 19 C.F.R. § 177.8(a)(3). The person seeking this treatment must overcome
that presumption with a request that is appropriately tailored and supported by evidence
establishing that: the information in question is customarily kept private or closely-held and either
that the government provided an express or implied assurance of confidentiality when the
information was shared with the government or there were no express or implied indications at the
time the information was submitted that the government would publicly disclose the information.
See Food Marketing Institute v. Argus Leader Media, 588 U.S. 427, 440 (2019) (concluding that
“[a]t least where commercial or financial information is both customarily and actually treated as
private by its owner and provided to the government under an assurance of privacy, the information
is ‘confidential’ within the meaning of exemption 4.”); see also U.S. Department of Justice, Office
of Information Policy (OIP): Step-by-Step Guide for Determining if Commercial or Financial
Information Obtained from a Person is Confidential Under Exemption 4 of the FOIA (updated
11/18/2022); and OIP Guidance: Exemption 4 after the Supreme Court’s Ruling in Food Marketing
Institute v. Argus Leader Media (updated 10/4/2019).
I. BACKGROUND
A. ITC Investigation No. 337-TA-1392
1. Procedural History at the ITC
The Commission instituted Investigation No. 337-TA-1392 on March 6, 2024, based on a
complaint filed by PAX. Certain Oil Vaporizing Devices, Components Thereof, and Products
Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 871272, Public Commission Opinion
(February 3, 2026) (“Comm’n Op.”) at 3. The complaint alleged a violation of section 337 by
reason of infringement of certain claims of U.S. Patent Nos. 11,369,756 (filed Mar. 17, 2021) (“the
’756 patent”); 11,369,757 (filed June 30, 2021) (“the ’757 patent”); 11,766,527 (filed Feb. 23,
2023) (“the ’527 patent”); and 11,759,580 (filed Feb. 23, 2023) (“the ’580 patent”) (collectively,
the “asserted patents”). Id. at 2. The complaint also alleged that the accused products were “certain
oil vaporizing devices, components thereof, and products containing the same” (collectively,
2
“Accused Products”). Id. at 3. The complaint further alleged that the respondents “import into the
United States, sell for importation into the United States, and/or sell in the United States after
importation Accused Products that infringe, directly or indirectly, one or more claims” of the
asserted patents. Certain Oil Vaporizing Devices, Components Thereof, and Products Containing
the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 812867, Public Complaint (January 30, 2024)
(“Complaint”) at 1. The notice of institution named STIIIZY and ALD Group Limited and ALD
(Hong Kong) Holding Limited (collectively, “ALD”) as respondents (collectively, “respondents”).
Certain Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, Inv. No.
337-TA-1392, EDIS Doc. ID. 815209, Notice of Institution of Investigation (February 29, 2024)
(“notice of institution”) at 2-3. The Commission’s Office of Unfair Import Investigation (OUII)
was not a party to the investigation. Comm’n Op. at 3.
Through various orders, the Commission terminated the investigation with respect to
certain claims of the asserted patents. Certain Oil Vaporizing Devices, Components Thereof, and
Products Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 825702, Order No. 11 (July
11, 2024), unreviewed by Comm’n Notice (July 30, 2024); and Certain Oil Vaporizing Devices,
Components Thereof, and Products Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID.
831665, Order No. 20 (Sept. 6, 2024), unreviewed by Comm’n Notice, EDIS Doc. ID. 834179,
(Oct. 7, 2024). Then, after an evidentiary hearing, the presiding Administrative Law Judge (ALJ)
terminated the investigation with respect to additional claims. Certain Oil Vaporizing Devices,
Components Thereof, and Products Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID.
836794, Order No. 32 (Nov. 8, 2024), unreviewed by Comm’n Notice, EDIS Doc. Id. 838932
(Dec. 10, 2024). At some point during the investigation, the respondents introduced several
redesigned products, including the STIIIZY-1G-REDESIGN(C), STIIIZY-ORIG-1G-
REDESIGN, and STIIIZY-AIO-REDESIGN (collectively, “STIIIZY Redesigned Products”).
Certain Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, Inv. No.
337-TA-1392, EDIS Doc. ID. 845893, Final Initial Determination (FID) (March 6, 2025),
reviewed in part by Comm’n Notice, EDIS Doc. Id. 851435 (May 16, 2025), at 24 (citing MSD,
EDIS Doc. ID. 830275). On March 6, 2025, the ALJ issued an FID. Comm’n Op. at 4. As of the
FID, the remaining claims at issue (“the asserted claims”) were claims 1, 5, and 10 of the ’756
patent; claims 1, 5, 10-11, 17-18, and 22 of the ’527 patent; claims 1, 13, 15, and 20 of the ’757
patent; and claims 1, 6-8, and 10 of the ’580 patent. Id.
In the FID, the ALJ found that the following Accused Products infringed at least one of the
asserted claims of at least one of the asserted patents: STIIIZY-LIIIL, STIIIIZY-1(G)(C), STIIIZY-
ORIG-1, STIIIZY-AIO (or “ITC AIO” as sometimes referred to by the parties), FLARE(C),
FLARE(V), ROVE(C), ROVE(V), STIIIZY-1G-REDESIGN(C), STIIIZY-ORIG-1G-
REDESIGNS, STIIIIZY-AIO-REDESIGN, FLARE-REDESIGN(C), and FLARE-
REDESIGN(V). FID at 111-112. Additionally, the FID held that the respondents’ ROVE-
REDESIGN(C) and ROVE-REDESIGN(V) did not infringe the asserted claims of the ’580 patent.
Id. at 100-101, and 112. With respect to the STIIIZY Redesigned Products noted above, the ALJ
found that each infringed at least one claim of the ’580 patent but not the ’756, ’757, and ’527
patents. Id. at 96, 98-99, and 112. Moreover, the ALJ noted that PAX did not introduce any
evidence that the STIIIZY Redesigned Products infringed the asserted claims of the ’756, ’757,
and ’527 patents and therefore failed to meet its burden of proof with respect to these patents. Id.
at 25, 60, and 72. The ALJ also held that STIIIZY presented no evidence to rebut PAX’s
3
contentions that the Accused Products indirectly infringed the asserted claims of the asserted
patents, both contributorily and by inducement. Id. at 27, 70, 72, and 103.
The FID also found that all the asserted claims were valid and that the technical prong of
the domestic industry requirement of section 337 was satisfied. Id. at 112-113. However, the ALJ
held that PAX did not meet the economic prong of section 337’s domestic industry requirement.
Id. at 113. As such, the ALJ found no violation of section 337. Id. at 109-112. In the FID, the
ALJ made a recommended determination (RD) that should the Commission find a section 337
violation, then an LEO should be issued against STIIIZY and ALD. Id. Moreover, the RD
recommended cease and desist orders (CDOs) against the STIIIZY respondents only. Id. at 114-
116. Lastly, the RD recommended that the Commission set a bond of one hundred percent (100%)
of the entered value for the importation of any infringing articles during the presidential review
period. Id. at 116-117.
The parties filed petitions with the Commission for review of the FID on March 18, 2025.
Comm’n Notice (May 16, 2025) at 2-3. The Commission issued a notice on May 16, 2025 that it
was reviewing the FID’s findings in part. Id. at 2. Specifically, the Commission indicated that it
was reviewing the FID’s findings that: (1) certain Accused Products did not infringe the asserted
claims of the ’580 patent; (2) certain redesigned products infringed the asserted claims of the ’580
patent; and (3) the Complainant had not satisfied the economic prong of the domestic industry
requirement. Id. at 3. On review, the Commission found that “the FID errs by stating as a bright-
line rule that ‘pre-issuance investments [are not] cognizable under subparagraphs (A) and (B) of
section 337(a)(3).’” Id. As such, the Commission vacated the FID’s findings on the economic
prong and remanded for further proceedings. Id. The Commission also indicated that the other
FID findings selected for review (“remaining issues”) remained pending. Id. Upon remand, the
Commission specifically requested that the ALJ “‘consider whether Complainant’s alleged
domestic industry investments were made with respect to the articles protected by the patent (i.e.,
the products that the FID finds satisfy the technical prong of the domestic industry requirement),
not limited by whether those investments were made post-patent issuance.’” Certain Oil
Vaporizing Devices, Components Thereof, and Products Containing the Same, Inv. No. 337-TA-
1392, Comm’n Notice, EDIS Doc. Id. 862213 (September 17, 2025) (citing Comm’n Notice May
16, 2025).
On July 18, 2025, the ALJ issued a Remand Initial Determination (RID) that PAX satisfied
the economic prong of the domestic industry requirement. Certain Oil Vaporizing Devices,
Components Thereof, and Products Containing the Same, Inv. No. 337-TA-1392, Remand Initial
Determination, EDIS Doc. Id. 858076 (July 30, 2025), at 23. On September 17, 2025, the
Commission issued a notice that it reviewed the RID and “otherwise affirms the RID’s findings
that the Complainant has satisfied the economic prong of the domestic industry requirement under
section 337(a)(3)(A) and (B), including its subsidiary finding that Complainant was an exclusive
licensee when it made its domestic industry investments.” Comm’n Op. at 4. In the notice, the
Commission requested written submissions from the parties with respect to their recommended
remedy should the Commission ultimately find a violation. Id. at 4-5. Both parties submitted their
briefs on remedy to the Commission in late November 2025. Id. at 7.
4
On February 3, 2026, the Commission issued its Opinion. See Comm’n Op. Concerning
the remaining issues, the Commission found that the ROVE(C), ROVE-REDESIGN(C), ROVE
(V), and ROVE-REDESIGN(V) products infringed certain claims of the ’580 patent. Id. at 2.
Moreover, the Commission affirmed the FID with additional reasoning that the STIIIZY-1G-
REDESIGN(C), STIIIZY-ORIG-1G-REDESIGN, and STIIIZY-AIO-REDESIGN products
infringed certain claims of the ’580 patent. Id. at 2. The Commission noted in its Opinion that it
did not review the FID’s findings with respect to the remaining asserted patents, except for the
economic prong of the domestic industry requirement, and as such adopted these findings. Id. at
2-3. Accordingly, the Commission found a violation of section 337 with respect to the asserted
patents. Id. at 27.
As for remedy, the Commission issued an LEO, including a standard certification
provision, against STIIIZY and ALD, as well as CDOs against both STIIIZY respondents. Id. at
3, 28. In the 1392 LEO, the Commission ordered that:
Certain oil vaporizing devices, components thereof, and products containing the
same, that infringe one or more of claims 1, 5, and 10 of the ’756 patent; claims 1,
5, 10, 11, 17, 18, and 22 of the ’527 patent; claims 1, 13, 15, and 20 of the ’757
patent; or claims 1, 6-8, and 10 of the ’580 patent and are manufactured abroad by,
or on behalf of, or imported by or on behalf of Respondents or any of their affiliated
companies, parents, subsidiaries, agents, or other related business entities, or its
successors or assigns, are excluded from entry for consumption into the United
States, entry for consumption from a foreign-trade zone, or withdrawal from a
warehouse for consumption, for the remaining terms of the Asserted Patents, except
under license from, or with the permission of, the patent owner or as provided by
law.
Certain Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, Inv. No.
337-TA-1392, EDIS Doc. ID. 869418, Limited Exclusion Order (January 20, 2026) at 2, ¶ 1.
The 1392 LEO further defined the “covered articles” as follows:
“Vaporizing devices capable of vaporizing oils, components thereof and products
containing the same” where the components of a vaporizing device are “a
mouthpiece, a cartridge body, an atomizer, a distal member, a bottom cover, a
vaporizer body including a cartridge receiver,” as well as a “battery,” and where
products containing the same are cartridge and battery components “sold in
combination with a power charging device in which the [cartridge] or battery would
each be one component of the downstream product.”
Id. at 2, ¶ 2. Lastly, the Commission determined that the public interest factors did not prevent
these remedial orders from being issued and required a bond of one hundred percent (100%) of the
entered value for infringing products to enter the U.S. during the presidential review period.
Comm’n Op. at 3.
On March 4, 2026, STIIIZY filed a petition for reconsideration, which was denied by the
Commission because it found that STIIIZY “[did] not identify any new questions raised by the
5
Commission’s determination or action ordered to be taken thereunder and upon which STIIIZY
had no opportunity to submit arguments.” Certain Oil Vaporizing Devices, Components Thereof,
and Products Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 874312, Order Denying
Respondent STIIIZY’s Petition for Reconsideration (March 4, 2026) at 3. Additionally, the
Commission found that “STIIIZY’s petition fails to demonstrate that the Commission should ‘on
its own initiative’ reconsider its finding of infringement under the doctrine of equivalents.” Id.
On March 9, 2026, STIIIZY filed a motion to stay the remedial orders of the Commission
pending appeal to the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”). Certain
Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, Inv. No. 337-
TA-1392, EDIS Doc. ID. 878118, Commission Opinion Denying Motion of Respondents STIIIZY
INC and STIIIZY IP LLC to Stay the Remedial Orders Pending Appeal (April 7, 2026) at 1. The
Commission denied STIIIZY’s motion for a stay because “STIIIZY has not shown that the
Standard Havens factors, as modified by the Commission’s jurisprudence, favor granting a stay
pending appeal.” Id. at 18. On March 23, 2026, STIIIZY filed a notice of appeal and emergency
motion to stay the remedial orders and for an interim administrative stay with the Federal Circuit.
Id. at 5 (citing STIIIZY, Inc. v. Int’l Trade Comm’n, No. 26-1554, Dkt. 2-3 (Fed. Cir. Mar. 23,
2026)). As of the date of this ruling letter, STIIIZY’s appeal before Federal Circuit remains
pending.
On May 6, 2026, PAX requested the Commission to institute an enforcement proceeding
against STIIIZY and ALD under 19 C.F.R. § 210.75. Certain Oil Vaporizing Devices, Components
Thereof, and Products Containing the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 882689,
Enforcement Complaint (May 20, 2026). The Commission instituted the enforcement proceeding
on June 5, 2026. Certain Oil Vaporizing Devices, Components Thereof, and Products Containing
the Same, Inv. No. 337-TA-1392, EDIS Doc. ID. 884319, Notice of Institution (June 5, 2026). As
of the date of this ruling letter, the enforcement proceeding remains pending before the
Commission.
2. The Patents and Asserted Claims in the 1392 LEO
As noted above, the 1392 LEO prohibits the unlicensed entry for consumption of certain
oil vaporizing devices, components thereof, and products containing the same that infringe the
asserted claims of the asserted patents. 1392 LEO at 2, ¶ 1. The asserted patents share a common
specification and are a continuation of application No. 15/396,584, now U.S. Patent No.
11,660,403 (filed Dec. 31, 2016). FID at 5-6. In general, “[t]he Asserted Patents are all directed
to ‘leak-resistant vaporizer cartridges and apparatuses adapted for use with oil-based vaporizable
materials including cannabis oils.’” Comm’n Op. at 8 (citing ’580 patent at code (57)). Figure 3B
of the ’580 patent is representative of the asserted patents and is reproduced below:
6
’580 patent at Fig. 3B. For purposes of this Ruling Request, the EOE Branch will adopt the claim
limitation labeling scheme presented in FID. FID at 16-17, 45-49, 66-68, and 77-80.
a. Claims 1, 5, and 10 of the ’756 patent
The ’756 patent is titled “Leak-Resistant Vaporizer Device” and describes “[v]aporizer
cartridges and vaporizer apparatuses, and methods for making, using, and delivering vapor to a
user, that are leak-resistant for use with cannabinoids.” ’756 patent at codes (54) and (57). Claim
1 of the ’756 patent is an independent claim and claims 5 and 10 depend from claim 1. Claim 1 is
reproduced below:
1. A vaporizer cartridge comprising [756.1.pre]:
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end [756.1.a];
a mouthpiece coupled to the proximal body end, the mouthpiece comprising an
outlet [756.1.b];
a reservoir comprising an internal volume at least partially defined by the cartridge
body, the internal volume configured to hold a vaporizable material [756.1.c];
a first reservoir seal [756.1.d];
a second reservoir seal, wherein the first reservoir seal and the second reservoir seal
are each configured to cover a corresponding reservoir opening exposing the
internal volume of the reservoir [756.1.e];
a first pad positioned within an interior of the mouthpiece [756.1.f];
a second pad positioned within the interior of the mouthpiece [756.1.g];
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, the bottom portion comprising: a first air opening and a second air
opening [756.1.h];
a first cartridge electrical contact configured to contact a first body electrical
contact on a vaporizer body [756.1.i];
a second cartridge electrical contact configured to contact a second body electrical
contact on the vaporizer body [756.1.j]; and
a heater chamber comprising [756.1.k]:
7
an atomizer configured to heat the vaporizable material from the reservoir to
generate an aerosol [756.1.k.i];
a housing piece configured to house at least a portion of the atomizer, the housing
piece comprising a housing opening into which at least a portion of the atomizer
passes into the housing piece [756.1.k.ii]; and
an air tube extending from the housing piece, the air tube configured to deliver the
aerosol from the atomizer to the mouthpiece [756.1.k.iii];
wherein the first pad and the second pad do not intersect with a central axis of the
air tube [756.1.l].
’756 patent at 34:48-35:16 and 36:1-11.
b. Claims 1, 13, 15, and 20 of the ’757 patent
The ’757 patent is titled “Leak-Resistant Vaporizer Device” and describes “[v]aporizer
cartridges and vaporizer apparatuses, and methods for making, using and delivering vapor to a
user, that are leak-resistant for use with cannabinoids.” ’757 patent at codes (54) and (57). Claims
1 and 15 are independent claims of the ’757 patent and claims 13 and 20 depend from claims 1
and 15, respectively. Claims 1 and 15 of the ’757 patent are reproduced below:
1. A vaporizer cartridge comprising [757.1.pre]:
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end [757.1.a];
a mouthpiece coupled to the proximal body end, the mouthpiece comprising an
outlet [757.1.b];
a reservoir configured to hold a vaporizable material [757.1.c];
a first pad positioned within an interior of the mouthpiece [757.1.d];
a second pad positioned within the interior of the mouthpiece [757.1.e];
a heater chamber comprising [757.1.f]:
a heater configured to heat the vaporizable material from the reservoir to generate
an aerosol [757.1.f.i];
a housing piece configured to house at least a portion of the heater, the housing
piece comprising a housing opening configured to receive at least a portion of the
heater [757.1.f.ii];
an air tube extending from the housing piece [757.1.f.iii];
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, the bottom portion comprising: a first air opening and a second air
opening; and [757.1.g]
a distal member positioned at least partially within the cartridge body between the
housing piece and the bottom cover, the distal member comprising [757.1.h]:
a proximal side [757.1.h.i];
a distal side opposite the proximal side [757.1.h.ii];
a lateral side extending between the proximal side and the distal side; and
[757.1.h.iii]
at least one recessed surface positioned on the lateral side [757.1.h.iv];
8
wherein an air chamber is formed between the distal member and the bottom
portion of the bottom cover [757.1.i]; and
wherein the first air opening and the second air opening of the bottom portion allow
air to pass into the air chamber [757.1.j].
15. A vaporizer device comprising: [757.15.pre]
a vaporizer cartridge, comprising [757.15.a]:
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end [757.15.a.i];
a mouthpiece coupled to the proximal body end, the mouthpiece comprising an
outlet [757.15.a.ii];
a reservoir configured to hold a vaporizable material [757.15.a.iii];
a first pad positioned within an interior of the mouthpiece [757.15.a.iv];
a second pad positioned within the interior of the mouthpiece [757.15.a.v];
a heater chamber comprising [757.15.a.vi]:
a heater configured to heat the vaporizable material from the reservoir to generate
an aerosol [757.15.a.vi.a];
a housing piece configured to house at least a portion of the heater, the housing
piece configured to receive at least a portion of the heater [757.15.a.vi.b];
an air tube extending from the housing piece [757.15.a.vi.c];
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, the bottom portion comprising: a first air opening and a second air
opening [757.15.a.vii];
a distal member positioned at least partially within the cartridge body between the
housing piece and the bottom cover, the distal member comprising [757.15.a.viii]:
a proximal side [757.15.a.viii.a];
a distal side opposite the proximal side [757.15.a.viii.b];
a lateral side extending between the proximal side and the distal side; and
[757.15.a.viii.c]
at least one recessed surface positioned on the lateral side [757.15.a.viii.d];
wherein an air chamber is formed between the distal member and the bottom
portion of the bottom cover; and [757.15.a.ix]
wherein the first air opening and the second air opening of the bottom portion allow
air to pass into the air chamber; [757.15.a.x]
a first cartridge electrical contact; and [757.15.a.xi]
a second cartridge electrical contact; and [757.15.a.xii]
a vaporizer body, comprising: [757.15.b]
a cartridge receiver configured to insertably receive the vaporizer cartridge, the
cartridge receiver comprising: [757.15.b.i]
a first body electrical contact configured to electrically couple to the first cartridge
electrical contact of the vaporizer cartridge; [757.15.b.i.a]
a second body electrical contact configured to electrically couple to the second
cartridge electrical contact of the vaporizer cartridge; [757.15.b.i.b]
an insertion end into which the vaporizer cartridge is inserted; and [757.15.b.i.c]
a base opposite the insertion end; and [757.15.b.i.d]
9
one or more LEDs, wherein the vaporizer device is configured to cause the one or
more LEDs to illuminate during the generation of the aerosol by the heater of the
vaporizer cartridge. [757.15.b.ii]
’757 patent at 34:30-65 and 36:1-15.
c. Claims 1, 5, 10-11, 17-18, and 22 of the ’527 patent
The ‘527 patent is titled “Leak-Resistant Vaporizer Device” and describes “[v]aporizer
cartridges and vaporizer apparatus, and methods for making, using and delivering vapor to a user,
that are leak-resistant for use with cannabinoids.” ’527 patent at codes (54) and (57). Claims 1,
11, and 18 of the ’527 patent are independent claims. Claims 5 and 10 depend from claim 1 and
claims 17 and 22 depend from claims 11 and 18, respectively. Claims 1, 11, and 18 of the ’527
patent are reproduced below:
1. A vaporizer cartridge comprising: [527.1.pre]
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end; [527.1.a]
a mouthpiece coupled to the proximal body end, wherein the mouthpiece comprises
an outlet; [527.1.b]
a reservoir comprising an internal volume at least partially defined by the cartridge
body, wherein the internal volume is configured to hold a vaporizable material;
[527.1.c]
a first reservoir seal configured to cover a first reservoir opening exposing the
internal volume of the reservoir; [527.1.d]
a second reservoir seal configured to cover a second reservoir opening exposing the
internal volume of the reservoir, wherein the first reservoir seal and the second
reservoir seal are positioned within an interior of the mouthpiece; [527.1.e]
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, wherein the bottom portion comprises at least a first air opening;
[527.1.f]
a first cartridge electrical contact configured to contact a first body electrical
contact on a vaporizer body; [527.1.g]
a second cartridge electrical contact configured to contact a second body electrical
contact on the vaporizer body; and [527.1.h]
a vaporization chamber comprising: [527.1.i]
a heating element configured to heat the vaporizable material from the reservoir to
generate an aerosol [527.1.i.i]
a wicking material comprising ceramic; [527.1.i.ii]
a housing piece configured to house at least a portion of the wicking material,
wherein the housing piece comprises a housing opening into which at least the
portion of the wicking material passes into the housing piece; and [527.1.i.iii]
an air tube configured to deliver the aerosol to the mouthpiece. [527.1.i.iv]
11. A vaporizer device, comprising: [527.11.pre]
10
a vaporizer cartridge comprising: [527.11.a]
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end; [527.11.a.i]
a mouthpiece coupled to the proximal body end, wherein the mouthpiece comprises
an outlet; [527.11.a.ii]
a reservoir comprising an internal volume at least partially defined by the cartridge
body, wherein the internal volume is configured to hold a vaporizable material;
[527.11.a.iii]
a first reservoir seal configured to cover a first reservoir opening exposing the
internal volume of the reservoir; [527.11.a.iv]
a second reservoir seal configured to cover a second reservoir opening exposing the
internal volume of the reservoir, wherein the first reservoir seal and the second
reservoir seal are positioned within an interior of the mouthpiece; [527.11.a.v]
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, wherein the bottom portion comprises at least a first air opening;
[527.11.a.vi]
a first cartridge electrical contact configured to contact a first body electrical
contact on a vaporizer body; [527.11.a.vii]
a second cartridge electrical contact configured to contact a second body electrical
contact on the vaporizer body; and [527.11.a.viii]
a vaporization chamber comprising: [527.11.a.ix]
a heating element configured to heat the vaporizable material from the reservoir to
generate an aerosol; [527.11.a.ix.a]
a wicking material comprising ceramic; [527.11.a.ix.b]
a housing piece configured to house at least a portion of the wicking material,
wherein the housing piece comprises a housing opening into which at least the
portion of the wicking material passes into the housing piece; and [527.11.a.ix.c]
an air tube configured to deliver the aerosol to the mouthpiece; and [527.11.a.ix.d]
a vaporizer body, comprising: [527.11.b]
a cartridge receiver configured to insertably receive the vaporizer cartridge,
[527.11.b.i]
wherein the cartridge receiver comprises: [527.11.b.ii]
a first body electrical contact configured to electrically couple to the first cartridge
electrical contact of the vaporizer cartridge; [527.11.b.ii.a]
a second body electrical contact configured to electrically couple to the second
cartridge electrical contact of the vaporizer cartridge; [527.11.b.ii.b]
an insertion end into which the vaporizer cartridge is inserted; and [527.11.b.ii.c]
a base opposite the insertion end; [527.11.b.ii.d]
a pressure sensor configured to detect a change in pressure, causing activation of
the vaporizer device; and [527.11.b.iii]
a channel extending between the base of the cartridge receiver and the pressure
sensor. [527.11.b.iv]
18. A vaporizer cartridge comprising: [527.18.pre]
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end; [527.18.a]
11
a mouthpiece coupled to the proximal body end, wherein the mouthpiece comprises
an outlet; [527.18.b]
a reservoir comprising an internal volume at least partially defined by the cartridge
body, wherein the internal volume is configured to hold a vaporizable material;
[527.18.c]
a first reservoir seal configured to cover a first reservoir opening exposing the
internal volume of the reservoir; [527.18.d]
a second reservoir seal configured to cover a second reservoir opening exposing the
internal volume of the reservoir, wherein the first reservoir seal and the second
reservoir seal are positioned within an interior of the mouthpiece; [527.18.e]
at least one pad positioned within an interior of the mouthpiece; [527.18.f ]
a bottom cover comprising a bottom portion positioned distally relative to the
cartridge body, wherein the bottom portion comprises at least a first air opening;
[527.18.g]
a first cartridge electrical contact configured to contact a first body electrical
contact on a vaporizer body; [527.18.h]
a second cartridge electrical contact configured to contact a second body electrical
contact on the vaporizer body; and [527.18.i]
a vaporization chamber comprising: [527.18.j]
a heating element configured to heat the vaporizable material from the reservoir to
generate an aerosol; [527.18.j.i]
a wicking material comprising ceramic; [527.18.j.ii]
a housing piece configured to house at least a portion of the wicking material,
wherein the housing piece comprises a housing opening into which at least the
portion of the wicking material passes into the housing piece; and [527.18.j.iii]
an air tube configured to deliver the aerosol to the mouthpiece. [527.18.j.iv]
’527 patent at 34:1-35:8, 36:1-43, and 38:6-62.
d. Claims 1, 6-8, and 10 of the ’580 patent
The ’580 patent is titled “Leak-Resistant Vaporizer Device” and describes “[v]aporizer
cartridges and vaporizer apparatuses, and methods for making, using and delivering vapor to a
user, that are leak-resistant for use with cannabinoids.” ’580 patent at codes (54) and (57). Claims
1 and 8 of the ’580 patent are independent and claims 6-7 and claim 10 depend from claims 1 and
8, respectively. Claims 1 and 8 are reproduced below:
1. A vaporizer cartridge comprising [580.1.pre]:
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end [580.1.a];
a mouthpiece coupled to the proximal body end, where the mouthpiece comprises
an outlet [580.1.b];
a reservoir configured to hold a vaporizable material [580.1.c];
a vaporization chamber comprising [580.1.d]:
12
a heater configured to heat the vaporizable material from the reservoir to generate
an aerosol [580.1.d.i];
a housing piece configured to house at least a portion of the heater, wherein the
housing piece comprises a housing opening configured to receive at least the
portion of the heater [580.1.d.ii]; and
an air tube extending from the housing piece, wherein the air tube is configured to
deliver the aerosol from the heater to the mouthpiece [580.1.d.iii];
an extension wire extending from the heater [580.1.e];
a bottom cover comprising a bottom portion, wherein the bottom portion comprises
at least one air opening [580.1.f]; and
a distal member positioned at least partially within the cartridge body between the
housing piece and the bottom portion of the bottom cover, wherein the distal
member comprises [580.1.g]:
a proximal side [580.1.g.i];
a distal side opposite the proximal side [580.1.g.ii];
a lateral side extending between the proximal side and the distal side [580.1.g.iii];
and
an extension feature having a cylindrical shape, wherein the extension feature
extends from the proximal side of the distal member [580.1.g.iv], and
wherein the extension feature comprises an opening extending therethrough that
allows air to pass through the distal member [580.1.g.v];
wherein at least a portion of the distal member comprises a perimeter that has a first
shape corresponding to a second shape of an inner surface of the cartridge body
[580.1.g.vi]; and
wherein at least a portion of the extension wire extends at least partially through
the distal member [580.1.g.vii];
wherein an air chamber is formed between the distal member and the bottom
portion of the bottom cover [580.1.h].
8. A vaporizer device, comprising: [580.8.pre]
a vaporizer cartridge, comprising: [580.8.a]
a cartridge body comprising a proximal body end and a distal body end opposite
the proximal body end; [580.8.a.i]
a mouthpiece coupled to the proximal body end, wherein the mouthpiece comprises
an outlet; [580.8.a.ii]
a reservoir configured to hold a vaporizable material; [580.8.a.iii]
a vaporization chamber comprising: [580.8.a.iv]
a heater configured to heat the vaporizable material from the reservoir to generate
an aerosol; [580.8.a.iv.a]
a housing piece configured to house at least a portion of the heater, wherein the
housing piece comprises a housing opening configured to receive at least the
portion of the heater; and [580.8.a.iv.b]
an air tube extending from the housing piece, wherein the air tube is configured to
deliver the aerosol from the heater to the mouthpiece; [580.8.a.iv.c]
an extension wire extending from the heater; [580.8.a.v]
13
a bottom cover comprising a bottom portion, wherein the bottom portion comprises
at least one air opening; [580.8.a.vi]
at least one cartridge electrical contact; and [580.8.a.vii]
a distal member positioned at least partially within the cartridge body between the
housing piece and the bottom portion of the bottom cover, wherein the distal
member comprises: [580.8.a.viii]
a proximal side; [580.8.a.viii.a]
a distal side opposite the proximal side; [580.8.a.viii.b]
a lateral side extending between the proximal side and the distal side; and
[580.8.a.viii.c]
an extension feature having a cylindrical shape, wherein the extension feature
extends from the proximal side of the distal member, and [580.8.a.viii.d]
wherein the extension feature comprises an opening extending therethrough that
allows air to pass through the distal member; [580.8.a.viii.e]
wherein at least a portion of the distal member comprises a perimeter that has a first
shape corresponding to a second shape of an inner surface of the cartridge body;
and [580.8.a.viii.f]
wherein at least a portion of the extension wire extends at least partially through
the distal member; [580.8.a.viii.g]
wherein an air chamber is formed between the distal member and the bottom
portion of the bottom cover; and [580.8.a.ix]
a vaporizer body, comprising: [580.8.b]
a cartridge receiver configured to insertably receive the vaporizer cartridge,
wherein the cartridge receiver comprises: [580.8.b.i]
at least one body electrical contact configured to electrically couple to the at least
one cartridge electrical contact of the vaporizer cartridge; [580.8.b.i.a]
an insertion end into which the vaporizer cartridge is inserted; and [580.8.b.i.b]
a base opposite the insertion end; [580.8.b.i.c]
a sensor configured to detect a draw on the mouthpiece, causing activation of the
heater; and [580.8.b.ii]
a channel extending from the base of the cartridge receiver to the sensor.
[580.8.b.iii]
’580 patent at 34:1-35:11 and 35:47-36:40.
3. The Accused Products from the Underlying Investigation
The Accused Products in the underlying investigation consisted of “numerous vaporizer
and vaporizer cartridge products.” FID at 3. The notice of institution described the Accused
Products as follows:
“[V]aporizing devices capable of vaporizing oils, components thereof and products
containing the same” where the components of a vaporizing device are “a
mouthpiece, a cartridge body, an atomizer, a distal member, a bottom cover, a
vaporizer body including a cartridge receiver,” as well as a “battery,” and where
14
products containing the same are cartridge and battery components “sold in
combination with a power charging device in which the [cartridge] or battery would
each be one component of the downstream product.”
Notice of Institution at 2. The Commission Opinion provided the following chart of the parties’
agreed upon representative Accused Products and which of the asserted patents these products
were alleged to have infringed:
Comm’n Op. at 10-11 (citing FID at 4 and JX-0459). PAX maintained that “[t]he accused
cartridges all have substantially the same components (e.g., mouthpiece, cartridge body,
atomizer/heater, bottom cover), and they all function in substantially the same way.” FID at 3
(citing CIB at 4). Moreover, according to the FID, the “accused vaporizers all include substantially
the same components (e.g., vaporizer cartridge, vaporizer body, battery), and they all function in
substantially the same way.” Id. (citing CIB at 5).
In its complaint, PAX provided the following annotated photographs of an accused product
alongside the domestic industry product:
15
Complaint at 8-9.
16
B. 19 C.F.R. Part 177 Ruling Request
1. Procedural History before CBP
On June 1, 2026, STIIIZY requested a ruling from CBP that its [[ ]] was not
subject to the 1392 LEO (“STIIIZY Third Ruling Request” or “previous ruling request”). STIIIZY
Third Ruling Request (June 1, 2026) at 1. On August 14, 2026, the EOE Branch issued a ruling
finding that STIIIZY did not meet its burden of proof that the [[ ]] was not infringing. See
HQ H361933 (August 14, 2026) (“underlying ruling”). Specifically, the Branch found that while
STIIIZY met its burden with respect to a number of the asserted claims of the asserted patents,
“STIIIZY has presented no specific arguments why the [[ ]] does not infringe claims 8
and 10 of the ’580 patent.” Id. at 39. Both of these claims were among the asserted claims of the
’580 patent listed in the 1392 LEO. We indicated in that ruling that “STIIIZY is free to file a ruling
request pursuant to 19 C.F.R. Part 177 addressing claims 8 and 10 of the ‘580 patent and
incorporating the findings of this ruling on all other claims listed in the 1392 LEO.” Id. at 41.
On August 18, 2026, STIIIZY submitted a confidential letter and Exs. 1-15 (collectively,
“STIIIZY Fourth Ruling Request”) in an email to CBP requesting an administrative ruling pursuant
to 19 C.F.R. Part 177 addressing claims 8 and 10 of the ’580 patent. STIIIZY Email to EOE
Branch, August 18, 2026. In the same email, STIIIZY indicated to the EOE Branch that it had
served a redacted version of the STIIIZY Fourth Ruling Request on PAX’s counsel. Id. On August
19, 2026, the EOE Branch sent an email to STIIIZY confirming receipt of the Fourth Ruling
Request. EOE Branch Email to STIIIZY, August 19, 2026. Also, on August 19, 2026, the Branch
sent an email to both parties requesting an initial conference call. On August 28, 2026, an initial
conference call was held in which the Branch discussed the procedural guidelines for this
administrative proceeding. In particular, the Branch informed both parties that because there was
only one independent claim at issue before CBP it would limit the filings in this proceeding to the
STIIIZY Fourth Ruling Request already filed, a PAX response, and a STIIIZY reply. Additionally,
both parties agreed to waive an oral discussion before the Branch. The Branch also told the parties
that they may incorporate the Branch’s findings in H361933 and any arguments made in the
previous ruling request to the ruling request before us. Following the initial conference call, the
EOE Branch emailed the parties, setting the remainder of the procedural schedule for this
proceeding as follows:
Deadline Event
Deadline for PAX to file a substantive
September 8, 2026 (Tuesday)
response to 177 request
Deadline for STIIIZY to file a reply to
September 15, 2026 (Tuesday) PAX’s substantive response to 177
request
October 6, 2026 (Tuesday) Target Date for EOE Branch Ruling
October 7-27, 2026 Potential Extension of Target Date
17
EOE Branch Email to Parties, August 28, 2026. That same day, STIIIZY emailed the EOE Branch
indicating that the parties had reached agreement on a non-disclosure agreement (NDA) and
attached the NDA to the email. STIIIZY Email to EOE Branch, August 28, 2026.
On September 8, 2026, PAX submitted both confidential and redacted versions of its
response to STIIIZY’s Fourth Ruling Request along with Ex. A and confidential and redacted
versions of Ex. B (collectively, “PAX Response”). PAX Email to EOE Branch and STIIIZY,
September 8, 2027. On September 15, 2026, STIIIZY submitted its reply (“STIIIZY Reply”).
STIIIZY Email to EOE Branch and PAX, September 15, 2026. Upon receipt of the STIIIZY’s
Reply, the administrative record upon which this ruling relies was completed.
2. The Article at Issue
The article at issue in this Fourth Ruling Request is a vaporizer device that STIIIZY calls
the “[[ ]] AIO Device” ([[ ]]). STIIIZY Fourth Ruling Request at 1. This is
the same article that was at issue in STIIIZY’s Third Ruling Request. See HQ H361933.
According to STIIIZY, “[[
]]. STIIIZY Third Ruling Request at 18 (citing STIIIZY Ex. 1 ¶ 12 to
STIIIZY Third Ruling Request). STIIIZY maintains that the [[ ]] “[[
]]” STIIIZY Third Ruling Request Ex. 1 ¶ 13. Moreover, STIIIZY asserts that “[[
]]” STIIIZY Third Ruling Request at 18 (citing STIIIZY Ex. 1 ¶ 12 to
STIIIZY Third Ruling Request). During the oral discussion in connection with STIIIZY’s Third
Ruling Request, STIIIZY presented the following slide depicting the [[ ]]:
STIIIZY Third Ruling Request Oral Discussion Presentation at 6.
According to Ramon Alarcon, the head of hardware engineering for STIIIZY, “[i]n
[[ ]], STIIIZY and ALD [[
]], which resulted in the [[ ]] AIO Device. The first working prototypes of the
[[ ]] AIO Device were fabricated [[ ]].” STIIIZY Ex. 1 ¶ 11. Mr. Alarcon
further asserts that the [[ ]] differs from the STIIIZY-AIO in a number of respects, and
provides the following CAD drawing of these devices side by side:
18
[[
]]
STIIIZY Ex. 1 ¶ 13.
According to Mr. Alarcon, differences between the STIIIZY-AIO and the [[ ]]
include the [[ ]], [[ ]], [[ ]], number of [[ ]], [[
]], [[ ]], number of [[ ]], and [[ ]]. STIIIZY
Ex. 1 ¶¶ 13-20. Mr. Alarcon indicates that “[f]irst production samples have been imported into the
United States.” STIIIZY Ex. 1 ¶ 11.
II. ISSUE
Whether STIIIZY has met its burden of proof in establishing that its [[ ]] does not
infringe the asserted claims in the asserted patents and is thus not subject to the 1392 LEO.
III. LEGAL FRAMEWORK
A. Section 337 Exclusion Order Administration
19
The Commission shall investigate any alleged violation of section 337 to determine, with
respect to each investigation conducted by it under this section, whether there is a violation of this
section. See 19 U.S.C. § 1337(b)(1) and (c). If the Commission determines, as a result of an
investigation under this section, that there is a violation of this section, it shall direct that the
articles concerned, imported by any person violating the provision of this section, be excluded
from entry into the United States unless the Commission finds based on consideration of the public
interest that such articles should not be excluded from entry. See 19 U.S.C. § 1337(d)(1).
When the Commission determines that there is a violation of section 337, it generally
issues one of two types of exclusion orders: (1) a limited exclusion order or (2) a general exclusion
order. See Fuji Photo Film Co., Ltd. v. ITC, 474 F.3d 1281, 1286 (Fed. Cir. 2007). Both types of
orders direct CBP to bar infringing products from entering the country. See Yingbin-Nature
(Guangdong) Wood Indus. Co. v. ITC, 535 F.3d 1322, 1330 (Fed Cir. 2008). “A limited exclusion
order is ‘limited’ in that it only applies to the specific parties before the Commission in the
investigation. In contrast, a general exclusion order bars the importation of infringing products by
everyone, regardless of whether they were respondents in the Commission's investigation.” Id. A
general exclusion order is appropriate only if two exceptional circumstances apply. See Kyocera
Wireless Corp. v. ITC, 545 F.3d 1340, 1356 (Fed. Cir. 2008). A general exclusion order may only
be issued if (1) “necessary to prevent circumvention of a limited exclusion order,” or (2) “there is
a pattern of violation of this section and it is difficult to Identify the source of infringing
products.” 19 U.S.C. § 1337(d)(2); see Kyocera, 545 F.3d at 1356 (“If a complainant wishes to
obtain an exclusion order operative against articles of non-respondents, it must seek a GEO
[general exclusion order] by satisfying the heightened burdens of §§ 1337(d)(2)(A) and (B).”).
In addition to the action taken above, the Commission may issue an order under 19 U.S.C.
§ 1337(i) directing CBP to seize and forfeit articles attempting entry in violation of an exclusion
order if their owner, importer, or consignee previously had articles denied entry on the basis of
that exclusion order and received notice that seizure and forfeiture would result from any future
attempt to enter articles subject to the same. An exclusion order under § 1337(d)—either limited
or general—and a seizure and forfeiture order under § 1337(i) apply at the border only and are
operative against articles presented for customs examination or articles conditionally released from
customs custody but still subject to a timely demand for redelivery. See 19 U.S.C. §§ 1337(d)(1)
(“The Commission shall notify the Secretary of the Treasury of its action under this subsection
directing such exclusion from entry, and upon receipt of such notice, the Secretary shall, through
the proper officers, refuse such entry.”); Id. at (i)(3) (“Upon the attempted entry of articles subject
to an order issued under this subsection, the Secretary of the Treasury shall immediately notify all
ports of entry of the attempted importation and shall identify the persons notified under paragraph
(1)(C).”) (emphasis added).
Significantly, unlike district court injunctions, the Commission can issue a general
exclusion order that broadly prohibits entry of articles that violate section 337 of the Tariff Act of
1930 without regard to whether the persons importing such articles were parties to, or were related
to parties to, the investigation that led to issuance of the general exclusion
order. See Vastfame Camera, Ltd. v. ITC, 386 F.3d 1108, 1114 (Fed. Cir. 2004). The
Commission also has recognized that even limited exclusion orders have broader applicability
beyond just the parties found to infringe during an investigation. See Certain GPS Devices and
20
Products Containing Same, Inv. No. 337-TA-602, Comm’n Op. at 17, n. 6, Doc ID 317981 (Jan.
2009) (“We do not view the Court’s opinion in Kyocera as affecting the issuance of LEOs [limited
exclusion orders] that exclude infringing products made by respondents found to be violating
Section 337, but imported by another entity. The exclusionary language in this regard that is
traditionally included in LEOs is consistent with 19 U.S.C. § 1337(a)(1)(B)-(D) and 19 U.S.C. §
1337(d)(1).”).
Moreover, “[t]he Commission has consistently issued exclusion orders coextensive with
the violation of section 337 found to exist.” See Certain Erasable Programmable Read Only
Memories, Inv. No. 337-TA-276, Enforcement Proceeding, Comm’n Op. at 11, Doc ID 43536
(Aug. 1991) (emphasis added). “[W]hile individual models may be evaluated to determine
importation and [violation], the Commission's jurisdiction extends to all models of [violative]
products that are imported at the time of the Commission’s determination and to all such products
that will be imported during the life of the remedial orders.” See Certain Optical Disk Controller
Chips and Chipsets, Inv. No. 337-TA-506, Comm’n Op. at 56-57, USITC Pub. 3935, Doc ID
287263 (July 2007).
Lastly, despite the well-established principle that “the burden of proving infringement
generally rests upon the patentee [or plaintiff],” Medtronic, Inc. v. Mirowski Family Ventures,
LLC, 571 U.S. 191 (2014), the Commission has held that Medtronic is not controlling precedent
and does not overturn its longstanding practice of placing the burden of proof on the party who, in
light of the issued exclusion order, is seeking to have an article entered for
consumption. See Certain Sleep-Disordered Breathing Treatment Systems and Components
Thereof, Inv. No. 337-TA-879, Advisory Opinion at 6-11. In particular, the Commission has
noted that the U.S. Court of Appeals for the Federal Circuit “has upheld a Commission remedy
which effectively shifted the burden of proof on infringement issues to require a company seeking
to import goods to prove that its product does not infringe, despite the fact that, in general, the
burden of proof is on the patentee to prove, by a preponderance of the evidence, that a given
article does infringe[.]” Certain Integrated Circuit Telecommunication Chips, Inv. No. 337-TA-
337, Comm’n Op. at 21, n.14, USITC Pub. 2670, Doc ID 217024 (Aug. 1993) (emphasis in
original) (citing Sealed Air Corp. v. ITC, 645 F.2d 976, 988-89 (C.C.P.A. 1981)).
This approach is supported by Federal Circuit precedent. See Hyundai Elecs. Indus. Co.
v. ITC, 899 F.2d 1204, 1210 (Fed. Cir. 1990) (“Indeed, we have recognized, and Hyundai does
not dispute, that in an appropriate case the Commission can impose a general exclusion order that
binds parties and non-parties alike and effectively shifts to would-be importers of potentially
infringing articles, as a condition of entry, the burden of establishing noninfringement. The
rationale underlying the issuance of general exclusion orders—placing the risk of unfairness
associated with a prophylactic order upon potential importers rather than American manufacturers
that, vis-a-vis at least some foreign manufacturers and importers, have demonstrated their
entitlement to protection from unfair trade practices—applies here [in regard to a limited exclusion
order] with increased force.”) (emphasis added) (internal citation omitted).
21
B. Patent Infringement
Determining patent infringement requires two steps. Advanced Steel Recovery, LLC v. X-
Body Equip., Inc., 808 F.3d 1313, 1316 (2015). The first is to construe the limitations of the
asserted claims and the second is to compare the properly construed claims to the accused
product. Id. To establish literal infringement, every limitation recited in a claim must be found in
the accused product whereas, under the doctrine of equivalents, infringement occurs when there is
equivalence between the elements of the accused product and the claimed elements of the patented
invention. Microsoft Corp. v. GeoTag, Inc., 817 F.3d 1305, 1313 (Fed. Cir. 2016). One way to
establish equivalence is by showing, on an element-by-element basis, that the accused product
performs substantially the same function in substantially the same way with substantially the same
result as each claim limitation of the patented invention, which is often referred to as the function-
way-result test. See Intendis GmbH v. Glenmark Pharms., Inc., 822 F.3d 1355, 1361 (Fed. Cir.
2016).
As for the first step above, “claim construction is a matter of law.” SIMO Holdings, Inc.
v. H.K. uCloudlink Network Tech., Ltd., 983 F.3d 1367, 1374 (Fed. Cir. 2021). Moreover, the
ultimate construction of a claim limitation is a legal conclusion, as are interpretations of the
patent’s intrinsic evidence (the patent claims, specifications, and prosecution
history). UltimatePointer, L.L.C. v. Nintendo Co., 816 F.3d 816, 822 (Fed. Cir. 2016) (citing Teva
Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 841, 190 L. Ed. 2d 719 (2015). “Importantly,
the person of ordinary skill in the art is deemed to read the claim term not only in the context of
the particular claim in which the disputed term appears, but in the context of the entire patent,
including the specification.” Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. 2005)
(en banc). “In some cases, the ordinary meaning of claim language as understood by a person of
skill in the art may be readily apparent even to lay judges.” Id. at 1314. In others, courts look to
public sources such as “the words of the claims themselves, the remainder of the specification, the
prosecution history, and extrinsic evidence concerning relevant scientific principles, the meaning
of technical terms, and the state of the art.” Id.
According to the Federal Circuit, “[t]o begin with, the context in which a term is used in
the asserted claim can be highly instructive.” Phillips, 415 F.3d at 1314 (“To take a simple
example, the claim in this case refers to ‘steel baffles,’ which strongly implies that the term
‘baffles’ does not inherently mean objects made of steel.”). The context in which a claim term is
used also includes the full chain of dependence as well as the remaining suite of claims and the
written description. See Inline Plastics Corp. v. EasyPak, LLC, 799 F.3d 1364, 1371 (Fed. Cir.
2015) (“Since the specification explicitly mentions the ‘alternative’ . . . there can be no debate
concerning the application of the doctrine of claim differentiation.”).
The second step to establish infringement involves a comparison of the claims, as properly
construed, to the accused product, which is a question of fact. Apple Inc. v. Samsung Elecs. Co.,
Ltd., 839 F.3d 1034, 1040 (Fed. Cir. 2016) (en banc). We apply this two-step analysis below.
22
IV. ANALYSIS
Based on the above framework, STIIIZY, as the adjudged infringer at the ITC and the party
seeking importation of the [[ ]], 1 has the burden of proof to establish that this article is
non-infringing by a preponderance of evidence and is therefore not subject to the 1392
LEO. See Hyundai Elecs. Indus. Co., 899 F.2d at 1210 (citing SSIH Equip. S.A. v United States
Int’l Trade Comm’n, 718 F.2d 365, 371 & n.10 (Fed. Circ. 1983)); Certain Integrated Circuit
Telecommunication Chips, Inv. No. 337-TA-337, Comm’n Op. at 21, n.14, USITC Pub. 2670,
Doc ID 217024. STIIIZY argues that its [[ ]] does not infringe the asserted claims of the
’756, ’757, ’527, and ’580 patents. STIIIZY Fourth Ruling Request at 2.
In their filings, STIIIZY and PAX dispute only a single limitation from one claim of the
’580 patent. See Parties’ Filings. See also Greenlaw v. United States, 554 U.S. 237, 243 (2008)
(“In our adversary system, in both civil and criminal cases, in the first instance and on appeal, we
follow the principle of party presentation. That is, we rely on the parties to frame the issues for
decision and assign to courts the role of neutral arbiter of matters the parties present.”)
(emphasis added); see also Astellas Pharma, Inc. v. Sandoz Inc., 2024 U.S. App. LEXIS 23669, at
*12 (Fed. Cir. 2024) (“It is for the parties—not the court—to chart the course of the litigation.”);
see also Certain Robotic Floor Cleaning Devices and Components Thereof, Inv. No. 337-TA-1252,
Initial Determination on Violation of Section 337 and Recommended Determination on Remedy
and Bonding, EDIS Doc. ID 783814 (Public) (October 7, 2022) at 10, FN 16 (“Given that
[complainant] did not dispute that the [relevant] products in this category are non-infringing,
this Initial Determination finds no reason to conclude otherwise.”) (emphasis added), aff’d,
Notice of Commission Final Determination Finding a Violation of Section 337, EDIS Doc. ID
792838 (Public) (March 21, 2023) (“All findings in the FID that are not inconsistent with the
Commission’s determination are affirmed.”).
In the underlying ruling, we concluded that STIIIZY had met its burden of proof to
establish that the [[ ]] does not infringe claims 1 and 6-7 of the ’580 patent, claims 1, 5,
and 10 of the ’756 patent, claims 1, 13, 15, and 20 of the ’757 patent, and claims 1, 5, 10-11, 17-
18, and 22 of the ’527 patent. HQ H361933 at 45. However, because STIIIZY did not present
any arguments that the [[ ]] did not practice claims 8 and 10 of the ’580 patent, we found
that STIIIZY had not met its overall burden of proof with respect to the 1392 LEO. We adopt our
findings in H361933 and consider here only whether STIIIZY has met its burden of proof with
respect to claims 8 and 10 of the ’580 patent. Regarding the remaining limitations of these claims,
because they have not been raised by the parties, the EOE Branch will not consider them here.
To prove non-infringement of an asserted patent, all a would-be importer has to prove is that its
product does not meet a single limitation of each of the asserted independent claims of that patent.
Gemstar-Tv Guide Int’l, Inc. v. Int’l Trade Comm’n, 383 F.3d 1352, 1363 (Fed. Cir. 2004)
(affirming ITC finding of non-infringement of the ’268 patent when substantial evidence showed
that accused products of respondent Scientific-Atlanta did not meet the limitation “means…for
1
The evidence shows that STIIIZY will purchase the [[ ]], which is the
manufacturer. [[ ]] will then import the [[ ]] into the U.S. STIIIZY Fourth Ruling
Request at 3.
23
displaying the television schedule” of claim 1 of that patent) (citing FID Opinion 2002 ITC LEXIS
812 at *186).
1. The Asserted Patents
The ’580 patent (claims 8, 10)
a. “a vaporizer cartridge” (limitation 580.8.a)
According to STIIIZY, the [[ ]] does not meet the “vaporizer cartridge” limitation
of claim 8 of the ’580 patent. STIIIZY Fourth Ruling Request at 24-27. Before considering
whether this feature of claim 8 is present in the [[ ]], however, we must first address PAX’s
argument that the EOE Branch erred in its construction of “vaporizer cartridge” in H361933. PAX
Response at 2 and 3-6. According to PAX, just because the Commission did not construe
“vaporizer cartridge” it “does not free the Branch to adopt a claim construction that is
irreconcilable with the Commission’s findings on the products before it.” Id. at 7. We address this
argument below.
1. Claim Construction of “Vaporizer Cartridge”
As we noted in the underlying ruling, the Commission did not expressly construe
“vaporizer cartridge.” H361933 at 27 (citing FID at 6-7). As such, the Branch performed its own
construction of this limitation. After reviewing the arguments by both parties in STIIIZY’s Third
Ruling Request, the Branch adopted STIIIZY’s proposed construction of “vaporizer cartridge” as
a “component that mates with and may be installed into a vaporizer base to form a vaporizer
device.” H361933 at 31. We cited extensive support from the specification and claims of the ’580
patent and found that this construction was consistent with the patentee’s intent. H361933 at 27-
29. Our approach followed Federal Circuit precedent. As the Federal Circuit has confirmed, “[t]he
words of a claim are generally given their ordinary and customary meaning as understood by a
person of ordinary skill in the art when read in the context of the specification and prosecution
history. There are only two exceptions to this general rule: 1) when a patentee sets out a definition
and acts as his own lexicographer, or 2) when the patentee disavows the full scope of a claim term
either in the specification or during prosecution.” Thorner v. Sony Computer Entm't Am. LLC, 669
F.3d 1362, 1365 (Fed. Cir. 2012) (emphasis added) (internal citations omitted). The Federal Circuit
has also notably held that "[a] fundamental rule of claim construction is that terms in a patent
document are construed with the meaning with which they are presented in the patent document.
Thus claims must be construed so as to be consistent with the specification, of which they are a
part." Merck & Co. v. Teva Pharms. USA, Inc., 347 F.3d 1367, 1371 (Fed. Cir. 2003) (emphasis
added). “Ultimately, the interpretation to be given a term can only be determined and confirmed
with a full understanding of what the inventors actually invented and intended to envelop with the
claim. The construction that stays true to the claim language and most naturally aligns with the
patent's description of the invention will be, in the end, the correct construction.” Renishaw PLC
v. Marposs Societa' Per Azioni, 158 F.3d 1243, 1250 (Fed. Cir. 1998) (citing Markman v. Westview
Instruments, Inc., 517 U.S. 370, 389 (1996); Young Dental Mfg. Co. v. Q3 Special Prods, 112 F.3d
1137, 1141 (Fed. Cir. 1997)).
24
In the ruling request before us now, STIIIZY contends that the Branch should apply the
same construction of “vaporizer cartridge” to claim 8 that it adopted in the underlying ruling.
STIIIZY Fourth Ruling Request at 22. According to STIIIZY, “‘if a claim term appears in more
than one claim it should be construed the same in each.’” Dayco Prods., 329 F.3d at 1371. The
Branch’s construction, therefore, [in the underlying ruling] applies equally to the term vaporizer
cartridge in claim 8.” Id. at 24. STIIIZY also argues that “[t]he construction [the Branch adopted
in the underlying ruling] is consistent with the plain meaning of cartridge, which standard
dictionaries define as a removable container designed for insertion into a larger piece of
equipment” and that “[h]ere, that ‘larger piece of equipment’ is the vaporizer device.” Id. at 21
(citing ’580 patent at 2:43-54, 3:64-4:1, cl. 6; STIIIZY Exs. 11-13). STIIIZY also contends that:
Following the Phillips framework, the Branch [in the underlying ruling] considered
the intrinsic evidence and (where not in conflict with that intrinsic evidence) the
testimony of the parties’ experts. It would have been improper for the Branch to
factor into its construction an infringement finding for an entirely different product.
See SmithKline Beecham Corp. v. Apotex Corp., 403 F.3d 1331, 1340 (Fed. Cir.
2005) (“[T]his court has repeatedly stated that a court must construe claims without
considering the implications of covering a particular product or process.”). PAX is
essentially asking the Branch to conduct an infringement analysis on the category
of all-in-one devices as a whole, not on a product-by-product basis. This flies in the
face of Federal Circuit precedent. See ABC Corp. I v. P’ship & Unincorporated
Associations Identified on Schedule “A”, 52 F.4th 934, 938 (Fed. Cir. 2022)
(faulting district court for conducting infringement analysis on accused products
“as a group, without providing a product-by-product analysis”).
STIIIZY Reply at 5. Lastly, STIIIZY asserts that “[t]he FID’s findings . . . reflect an application
of the vaporizer cartridge limitation to specific devices (legacy AIO products) with specific
features (an alleged ‘cartridge component’), rather than a construction of the term that would
govern all future products.” Id.
On the other hand, PAX does not offer its own express construction of “vaporizer cartridge”
here. PAX Response at 3-6. Instead, PAX asserts that our previous construction contradicts the
Commission’s findings that several legacy AIO products met this limitation. Id. at 6-7. Here, PAX
contends that “[c]ritically, the FID found that all AIO devices, including the representative
STIIIZY-LIIIL, the STIIIZY-AIO, and STIIIZY-AIO-REDESIGN [collectively, the “legacy AIO
devices”], each satisfy the ‘vaporizer cartridge’ preamble limitation across the Asserted Patents.”
Id. at 4. To this end, PAX asserts that “[a] construction of ‘vaporizer cartridge’ that excludes the
[[ ]] AIO Device would also exclude the STIIIZY-AIO” and that “[u]nder a construction
consistent with the Commission’s findings, the [[ ]] AIO Device satisfies the so-called
‘vaporizer cartridge’ limitation of independent claims 1 and 8 and dependent claim 10 of the ‘580
Patent.” Id. at 3.
As noted above, PAX argues that just because the Commission did not construe “vaporizer
cartridge” it “does not free the Branch to adopt a claim construction that is irreconcilable with the
Commission’s findings on the products before it.” Id. at 7. According to PAX, “[t]hese undisputed
findings across all three AIO product lines—each of which is an integrated all-in-one device—
25
establish that the Commission’s construction of ‘vaporizer cartridge’ is broad enough to encompass
such integrated devices. STIIIZY’s proposed construction, which would require a ‘vaporizer
cartridge’ to mate with and be installed into a separate vaporizer base, is irreconcilable with these
findings and cannot be adopted by CBP.” Id. at 6. In this regard, PAX asserts that “[t]he
Commission’s infringement finding on the AIO devices necessarily implies a construction of
‘vaporizer cartridge’ broad enough to encompass the class of integrated all-in-one vaporizer
devices” and that CBP is “bound to that implied construction.” Id. at 6-7.
Lastly, PAX maintains that:
Notably, STIIIZY did not dispute that any of these AIO products satisfied the
“vaporizer cartridge” preamble in the underlying investigation. STIIIZY’s failure
to contest the “vaporizer cartridge” limitation as applied to its own AIO products in
the underlying investigation constitutes a forfeiture of any argument that an
integrated all-in-one device cannot satisfy that limitation. STIIIZY cannot now, in
a Part 177 proceeding, advance a claim construction for “vaporizer cartridge” that
it never raised before the ALJ or the Commission and that would render the
Commission’s own infringement findings impossible.
Id. at 5.
Initially, we note that PAX did not request a reconsideration of the underlying ruling. See
generally PAX Response. As such, CBP is bound to its findings in H361933 until revoked or
modified. See 19 C.F.R. § 177.9(a). With this in mind, we now address PAX’s argument that the
Commission engaged in implicit claim construction of “vaporizer cartridge.” Id. at 6-7. According
to the Federal Circuit, “[l]ess clear, at times, is whether a court or other tribunal has construed a
claim or whether it has simply compared the claim to prior art or an allegedly infringing
technology. While the line between these two inquiries can be fine, the answer could be critical
given the different standard of review applicable to each issue on appeal.” Google LLC v.
Ecofactor, Inc., 92 F.4th 1049, 1055 (Fed. Cir. 2024) (citing Dionex Softron GmbH v. Agilent
Techs., Inc., 56 F.4th 1353, 1358 (Fed. Cir. 2023); Fleming v. Cirrus Design Corp., 28 F.4th 1214,
1221-22 (Fed. Cir. 2022); and Amgen Inc. v. Hospira, Inc., 944 F.3d 1327, 1335 (Fed. Cir. 2019)
(emphasis in original)). The Federal Circuit in Google further surmised that:
To determine whether a court, or the Board, has construed a claim, it is helpful to
look to the outcome of the tribunal's analysis. See HTC Corp., 877 F.3d at 1367
(determining that a claim construction occurred where the Board's findings
established the scope of the patented subject matter). If the outcome of the analysis
of the claim term establishes the scope (e.g., boundaries) and meaning of the
patented subject matter, the court (or the Board) has mostly likely construed the
claim. See Netword, 242 F.3d at 1352; see also Trading Techs. Int'l, Inc. v. Open E
Cry, LLC, 728 F.3d 1309, 1319 (Fed. Cir. 2013).
Google, 92 F.4th at 1055 (emphasis in original). In Google, the Federal Circuit found that the
Patent Trial and Appeal Board (PTAB) performed claim construction of the disputed limitation
even though the PTAB stated in its Final Written Decision that “because no express construction
26
is needed for our decision, we do not construe any of the claim limitations.” Id. The Federal
Circuit reviewed the record and concluded that the PTAB made a detailed analysis of this
limitation, including citing several Federal Circuit cases that supported its findings. Id. at 1056.
Using this analysis, the Board rejected Google’s challenge to the validity of the underlying patent.
Id. The Federal Circuit found that “the outcome of the Board’s assessment established the scope
of the [] limitation [at issue]” and that, despite the Board’s contentions to the contrary, its findings
“amount[] to claim construction.” Id.
Here, we find that the Commission did not implicitly construe “vaporizer cartridge.”
Unlike the Board’s assessment in Google, there was no analysis of “vaporizer cartridge” in the
Commission’s findings in the underlying investigation. As stated in the underlying ruling, we
found that the Commission simply made factual findings that the STIIIZY AIO met the “vaporizer
cartridge” preamble of claim 1 of the ’580 patent. H361933 at 33 (citing FID at 82-83 and CX-
4747C (Kodama) at Q/As 326-327)). Although the Commission cited the Amended Witness
Statement of PAX’s expert Kelly Kodama in its findings, we found his testimony insufficient in
proving that the [[ ]] met this limitation. H361933 at 35. Unless the Commission
analyzed this limitation such that it establishes its scope, as required by Google, we cannot
conclude it implicitly construed “vaporizer cartridge.” See also Bissel, Inc. v. Int’l Trade Comm’n,
175 F.4th 1327, 1334 (Fed. Cir. 2026) (holding that appellant Bissel could not rely on Google LLC
v. EcoFactor, Inc. for a finding of implicit claim construction by the ALJ when the ALJ did not
“establish the scope of [the disputed] limitation” by merely applying the plain and ordinary
meaning of the limitation to the article at issue). Accordingly, in the absence of an express or
implicit claim construction by the Commission that provides us with clear guidance, the Branch
must adopt its own claim construction of “vaporizer cartridge” that does not conflict with the
Commission’s findings. We note that, despite arguing that there was an implicit claim construction
by the Commission, PAX has not articulated what that claim construction was. See Pax Response
at 7.
We also reject PAX’s argument that our claim construction of “vaporizer cartridge”
contradicts the Commission’s findings of infringement of the legacy AIO devices. PAX Response
at 3. PAX argues that the STIIIZY legacy AIO devices met the “vaporizer cartridge” limitation in
the underlying investigation and that therefore our claim construction contradicts this finding.
PAX Response at 4. Specifically, according to PAX:
These products are integrated devices in which the reservoir, heater, and battery are
housed within a single unit, and none of them mates with a separate vaporizer base
in the manner that STIIIZY now contends is required by the term “vaporizer
cartridge.” Notwithstanding that structural characteristic, the Commission found
each of these products to infringe claims requiring a “vaporizer cartridge.” Those
findings are final and conclusive and are binding on CBP.
Id. We disagree that the legacy AIO devices do not conform to our claim construction of
“vaporizer cartridge.” Specifically, we found in the underlying ruling that the STIIIZY AIO has a
“component that mates with and may be installed into a vaporizer base to form a vaporizer body.”
H361933 at 33, n. 3. PAX’s own evidence from the underlying investigation confirms this, as
27
shown in the below photos of the cartridges of the legacy AIO devices presented by its expert
Kelly Kodama in his Amended Witness Statement.
PAX Ex. B at 109. According to Kelly Kodama, the STIIIZY legacy AIO devices all have
cartridges and battery components. PAX Ex. B at Q/A at 182 (“The battery component of the
STIIIZY LIIIL Vaporizer serves as the vaporizer body”); Q/A at 183 (“The battery component of
the STIIIZY AIO Vaporizer serves as the vaporizer body”); and Q/A 440 (“the STIIIZY AIO
Vaporizer Redesign has substantially the same features as the STIIIZY AIO Vaporizer…”).
Clearly, these cartridges must be inserted into a vaporizer body (i.e., battery) to form a vaporizer
device. Although users of the legacy AIO devices themselves cannot perform this function (i.e.,
it is done by the manufacturer), neither our claim construction nor the Commission’s findings
require that the users be the ones that do so. Therefore, the Branch’s claim construction of
“vaporizer cartridge” in H361933 was consistent with the infringement findings of the
Commission.
We lastly turn to PAX’s claim that “STIIIZY cannot now, in a Part 177 proceeding, advance
a claim construction for ‘vaporizer cartridge’ that it never raised before the ALJ or the Commission
and that would render the Commission’s own infringement findings impossible.” PAX Response
to STIIIZY’s Fourth Ruling Request at 5. The Branch finds this argument unavailing. Neither the
[[ ]] nor a similar device was before the Commission. As STIIIZY argues, “[t]he
underlying ITC proceeding and this Part 177 Request involve materially different products.
STIIIIZY could not have waived this argument during the underlying investigation because the
argument could not have been made during the underlying investigation.” STIIIZY Reply at 8.
We agree. STIIIZY was not required to advance a claim construction at the Commission for a
limitation not in dispute. FID at 82, 98. Therefore, by failing to do so, it does not follow that
STIIIZY forfeited any claim construction arguments here.
28
After considering the evidence and arguments before us, the Branch adopts the same claim
construction of “vaporizer cartridge” that it did in the underlying ruling. H361933 at 31. PAX has
not provided any new arguments for why the Branch should depart from this construction. Rather,
PAX largely relies on the same arguments that we already considered and rejected in H361933.
Although we acknowledge that CBP is bound by the findings of the Commission, CBP has
authority to decide issues that the Commission has not addressed in connection with our authority
over prospective transactions under 19 C.F.R. 177. Here, we find that Commission did not
expressly or implicitly construe “vaporizer cartridge.” See Order No. 19, FID, Comm’n Op; and
supra at 26. Accordingly, for the same reasons we articulated in H361933 for claim 1 of the ’580
patent, the Branch finds that “vaporizer cartridge” should be construed as a “component that mates
with and may be installed into a vaporizer base to form a vaporizer device” for claim 8 of this
patent. H361933 at 31.
2. Whether the [[ ]] Meets the “Vaporizer Cartridge” Limitation
The Branch now considers whether the [[ ]] practices the “vaporizer cartridge”
limitation of claim 8 of the ’580 patent based on the above claim construction. According to
STIIIZY in its Third Ruling Request:
[T]he [[ ]] AIO Device does not pair with a vaporizer base and does not
contain a component that mates with or is installed into a vaporizer base. Even
PAX’s expert agreed that “the [[ ]] AIO Device is “an all-in-one (‘AIO’)
vaporizer device in which a battery is not detachable from a cartridge.” (Ex. 14,
Kodama Decl. ¶ 15. Accordingly, there is no component that literally meets the
Branch’s construction, i.e. one that “mates with and may be installed into a
vaporizer base to form a vaporizer device.” (emphasis in original) (some internal
citations omitted).
STIIIZY Third Ruling Request at 22. Additionally, STIIIZY asserts that:
Nor is the [[ ]] AIO Device a vaporizer cartridge under the doctrine of
equivalents. The [[ ]] AIO Device does not contain any structure that
performs the function of a vaporizer cartridge (mating with a base) in substantially
the same way (through electrical contacts that engage upon insertion) to achieve
substantially the same result (forming a vaporizer device by pairing separable
components). (Ex. 11, Wensley Decl. ¶ 28; Ex. 10 at 32 (“[W]e do not find this
[vaporizer cartridge] feature or its equivalent present in the [[ ]].”).)
Id. (emphasis in original).
Lastly, STIIIZY argues that “PAX mischaracterizes the FID by claiming that ‘all AIO
devices . . . satisfy the “vaporizer cartridge” preamble limitation across the Asserted Patents.’ To
the contrary, the FID did not broadly rule that all integrated vaporizer devices necessary satisfy the
vaporizer cartridge limitation. Rather, its rulings related only to particular devices, none of which
are at issue here.” STIIIZY Reply at 4 (internal citations omitted) (emphasis in original).
29
Conversely, PAX contends that “the Branch’s construction of ‘vaporizer cartridge’ in the
Prior Ruling is irreconcilable with the Commission’s infringement findings and cannot be applied
in this proceeding. Under a construction consistent with those findings, which is broad enough to
encompass the class of integrated all-in-one vaporizer devices, which the Commission found to
infringe claim 1, the [[ ]] AIO Device likewise satisfies the ‘vaporizer cartridge’ limitation
of claims 8 and 10.” PAX Response at 7. In this regard, PAX further asserts that:
The Commission’s finding that STIIIZY earlier AIO devices satisfy the “vaporizer
cartridge” limitation establishes that an integrated all-in-one vaporizer device can
constitute or contain a “vaporizer cartridge” within the meaning of the ‘580 Patent.
The [[ ]] AIO Device is similarly an integrated all-in-one vaporizer device.
The [[ ]] AIO Device therefore satisfies the “vaporizer cartridge”
limitation of claim 8 for the same reasons the Commission found the STIIIZY AIO
devices to satisfy the corresponding limitation of claim 1.
Id. at 7 (internal citations omitted).
Moreover, PAX argues that the “STIIIZY-AIO is a representative product for all AIO
variants of the STIIIZY All-In-One Vaporizer. Accordingly, the Commission’s findings that the
STIIIZY-AIO satisfies the ‘vaporizer cartridge’ preamble applies to all AIO variants of that product
line.” Id. at 4 (citing PAX Ex. A, Joint Stipulation re Representative Products (“Joint Product
Stipulation”) at 3). PAX makes similar contentions regarding the STIIIZY-AIO-REDESIGN and
STIIIZY LIIIL. PAX Response at 4-5 (citing PAX Ex. A at 3). Here, PAX argues that the legacy
AIO devices “are integrated devices in which the reservoir, header, and battery are housed within
a single unit, and none of them mates with a separate vaporizer base in the manner that STIIIZY
now contends is required by the term ‘vaporizer cartridge.’” Id. at 4.
PAX also asserts that STIIIZY admitted that the [[ ]] has both cartridge and
battery components. According to PAX, “STIIIZY’ [sic] own submissions confirm that the
[[ ]] AIO Device is an integrated all-in-one vaporizer device in which the battery is not
detachable from the cartridge—the same structural characteristic shared by the STIIIZY AIO
devices that the Commission found to satisfy the ‘vaporizer cartridge’ limitation.” PAX Response
at 4-5 (citing STIIIZY Ex. 1 at ¶¶ 12-15).
We conclude that the preponderance of evidence supports a finding that the [[ ]]
does not have a “vaporizer cartridge” as construed by the Branch, as set forth above and previously
in H361933. As we indicated in the underlying ruling, we reject PAX’s contentions that the Branch
must apply the Commission’s findings of the “vaporizer cartridge” limitation that it made for the
legacy AIO devices to the [[ ]] here. H361933 at 32. In H361933, we extensively
discussed the differences between the STIIIZY AIO and the [[ ]]. H361933 at 32-33. In
particular, we noted the clear differences between the STIIIZY AIO and the [[ ]] as shown
in the following slide presented by STIIIZY during the oral discussion in its Third Ruling Request:
30
[[
]]
Id. (citing STIIIZY Oral Presentation in STIIIZY Third Ruling Request at 54). There, we found
the following:
From the lefthand photo of the cartridge of the STIIIZY-AIO above, one can readily
see a vaporizer cartridge, which just one of the components of the STIIIZY-AIO.
In contrast, we do not see a vaporizer cartridge that can mate with a vaporizer base
to form a vaporizer device in the [[ ]] on the right. In fact, the CAD
drawing of the [[ ]] shows that the device is a single unit that does not need
to mate with another component to form a vaporizer device. From the Branch’s
perspective, just because the ALJ found that the STIIIZY-AIO infringed the
preamble of the ’580 patent, it does not follow that we are required to find that
another all-in-one device (the [[ ]]) has this same feature. This is especially
true considering the [[ ]] is distinctive in numerous ways from STIIIZY-
AIO and the Commission did not consider a similar all-in-one product during the
underlying investigation.
H361933 at 33.
We also note again that the FID did not specifically indicate why the STIIIZY-AIO met the
“vaporizer cartridge” limitation of claim 1 of the ’580 patent. FID at 82-83 (citing CX-4747C
(Kodama) at Q/As 326-327, 333). It is worth considering again the evidence cited by the ALJ for
this limitation. In the FID, the ALJ briefly cited, but did not quote from, the testimony below of
Kelly Kodama. FID at 83. In the Amended Witness Statement of Kelly Kodama that the ALJ
cited, the following question and answer exchange occurred:
Q326. Let’s turn to the details of your analysis for claim 1 of the ’580 Patent,
and for each element I’m going to ask you to explain your analysis
relative to the following representative products: . . . STIIIZY All-In-
One Vaporizer . . . . Are any of these accused products a vaporizer
cartridge as recited in the preamble of claim 1?
A326. Yes, Slide CDX-0001.0105 shows that the STIIIZY 1 Gram Cartridge, Rove
Cartridge, Flare X2 Cartridge, STIIIZY 1 Gram Cartridge Redesign, Rove
Cartridge Redesign, and Flare X2 Cartridge Redesign are vaporizer
cartridges.
31
Q327. Do any of these accused vaporizer products include a vaporizer
cartridge as recited in the preamble of claim 1?
A327. Yes, the STIIIZY (Original) Vaporizer with 1 Gram Cartridge, the STIIIZY
LIIIL Vaporizer, STIIIZY All-In-One Vaporizer, Rove Vaporizer, Flare X2
Vaporizer, STIIIZY (Original) Vaporizer with 1 Gram Cartridge Redesign,
STIIIZY All-In-One Vaporizer Redesign, Rove Vaporizer with Rove
Cartridge Redesign, and Flare X2 Vaporizer with Flare X2 Cartridge
Redesign all include vaporizer cartridges.
...
The vaporizer cartridge component of the STIIIZY All-In-One Vaporizer
Redesign is shown on slide CDX-0001.0106.
...
Q333. Does the STIIIZY AIO Vaporizer satisfy elements [1A]-[1C]?
A333. Yes, the mouthpiece, cartridge body, and reservoir of the cartridge
component of the STIIIZY AIO Vaporizer are identified on slide CDX-
0001.0112. Relative to elements [1A]–[1C], the cartridge component has
substantially the same features as the STIIIZY 1 Gram.
PAX Ex. B, Q/A 326-327, 333. See also H361933 at 33-34.
As part of his Amended Witness Statement, Mr. Kodama provided the following slide with
respect to Q/A 327 above:
PAX Ex. B, Q/A 327. See also H361933 at 34.
32
Thus, we found in H361933 that although the ALJ cited Mr. Kodama’s witness statement
as evidence that the STIIIZY-AIO infringed claim 1 of the ’580 patent, Mr. Kodama gave no
specifics as to why this device met the “vaporizer cartridge” limitation. PAX Ex. B, Q/As 326-
327, 333. Rather, Mr. Kodama made general statements concerning infringement and provided a
slide with a photograph of the cartridge of the STIIIZY-AIO (i.e., middle device in above
photograph). From this alone, as we indicated in the underlying ruling, the Branch cannot conclude
that the ITC’s findings on the STIIIZY-AIO warrant a similar finding that an entirely different
article with a different structure and functionality, the [[ ]], meets the “vaporizer cartridge”
limitation of claim 8. H361933 at 35; see supra p19. As such, we again find Mr. Kodama’s
testimony from the underlying investigation insufficient to prove that the [[ ]] contains a
“vaporizer cartridge.”
The additional arguments made by PAX are also unavailing. As stated above, PAX alleges
that STIIIZY’s “own submissions confirm that the [[ ]] AIO Device is an integrated all-
in-one vaporizer device in which the battery is not detachable from the cartridge.” PAX Response
at 6 (citing STIIIZY Ex. 1 at ¶¶ 12-15). We disagree. We have reviewed STIIIZY’s Exhibit 1
(Declaration of Ramon Alarcon) cited by PAX and did not locate this alleged admission by Mr.
Alarcon. Moreover, PAX’s assertion that the STIIIZY legacy AIO devices are “integrated devices
in which the reservoir, heater, and battery are housed within a single unit, and none of them mates
with a separate vaporizer base in the manner that STIIIZY now contends is required by the term
‘vaporizer cartridge’” is misleading. The Commission specifically found that these devices also
include a vaporizer cartridge. FID at 82-83, 98.
The Branch also rejects PAX’s argument that the [[ ]] is representative of the
STIIIZY legacy AIO devices and variants thereof listed in the parties’ Joint Product Stipulation.
PAX Response at 4-5 (citing PAX Ex. A at 3). Initially, we note that the Joint Product Stipulation
does not reference a [[ ]] type device. Additionally, for the STIIIZY LIIIL and STIIIZY
AIO, the agreed-upon representative products listed in the Joint Product Stipulation are merely
variants in flavor and strain type. PAX Ex. A, Attachments E, F. Moreover, for the STIIIZY AIO
Vaporizer Redesign, the parties stipulated that it “shall be representative of all future variants of
the STIIIZY All-in-One Vaporizer Redesign that reflect only cosmetic and/or flavor differences
compared to the STIIIZY All-in-One Vaporizer Redesign.” PAX Ex. A at 4. We find that the
[[ ]] is not simply a variation in flavor or strain or a cosmetic variant of the STIIIZY legacy
AIO devices. As we held in held in the underlying ruling, and again here, the [[ ]] is a
completely different product than any that was adjudicated in the underlying investigation.
H361933 at 32-33.
We also agree with STIIIZY that “PAX mischaracterizes the FID by claiming that ‘all AIO
devices . . . satisfy the “vaporizer cartridge” preamble limitation across the Asserted Patents.’”
STIIIZY Reply at 4. A review of the record in the underlying investigation reveals that the
Commission only made findings on several AIO devices, including the STIIIZY LIIIL, STIIIZY
AIO, and STIIIZY AIO Redesign. At no point did the Commission make a finding that all AIO
devices, no matter their structure, infringe the asserted patents. See FID and Comm’n Op.
Moreover, STIIIZY’s branding of the [[ ]] as an AIO is not an admission that it is the same
as the legacy AIO devices or a concession that it has a cartridge. By definition, an all-in-one is
simply a device that contains all its parts or functionalities in one unit. All-In-One, Collins.com,
33
https://www.collinsdictionary.com/dictionary/english/all-in-one (“denoting a product or system
that combines multiple parts or functions”) (last visited Sept. 28, 2026)). However, not every all-
in-one device is created the same. In fact, the specification of the ’580 patent discloses that
vaporizer devices may be cartridge-less, [[ ]]. ’580 patent at 2:43-
45; 32:13-17.
Lastly, we reiterate here, as we found before, that PAX has not pointed to any feature in the
[[ ]] that satisfies the “vaporizer cartridge” limitation. See PAX Response at 7-8. Rather,
PAX’s arguments are restricted to its disagreement with our claim construction and its assertion
that CBP is bound to apply the Commission’s findings on the legacy AIO devices to the
[[ ]]. In other words, PAX has failed to provide an alternative argument of what feature of
the [[ ]] meets this limitation under the Branch’s claim construction. Accordingly, its
argument is unpersuasive.
3. Our Overall Findings on the “Vaporizer Cartridge” Limitation of Claim 8
After reviewing the parties’ filings, the underlying investigative record, and Federal Circuit
precedent, we find that the [[ ]] does not practice the “vaporizer cartridge” limitation of
claim 8. As noted above, we maintain our claim construction of this limitation that we adopted in
H361933. Furthermore, based on this claim construction, we find that the [[ ]] does not
meet the limitation “vaporizer cartridge” of claim 8 because the preponderance of the evidence
supports a finding that this feature is not present in the [[ ]].
b. The Remaining Limitations of Claim 8
Concerning the other limitations of claim 8, STIIIZY argues that “[i]f necessary, STIIIZY
reserves the right to introduce evidence that additional claim limitations (i.e., those addressed by
STIIIZY in its June 1, 2026 proceeding for claim 1 of the ’580 Patent that also appear in claim 8,
such as extension feature, vaporization chamber, and the like) are not satisfied by the
[[ ]] device for claim 8 for the same reasons these limitations are not found in claim 1.”
STIIIZY Fourth Ruling Request at 27 (emphasis in original). The Branch did not consider these
limitations in H361933 with respect to claim 1 because we found that the [[ ]] did not
meet the preamble “vaporizer cartridge.” See H361933 at 35-39. These limitations are also found
in claim 8 of the ’580 patent. ’580 patent at 35:47-36:40. Because we conclude that the
[[ ]] does not practice the “vaporizer cartridge” limitation of claim 8, we need not consider
these remaining limitations.
c. The EOE Branch’s Overall Position on the ’580 patent
In conclusion, the Branch finds that STIIIZY has met its burden of proof in showing the
[[ ]] does not infringe claim 8 of the ’580 patent. Because claim 10 depends from claim
8, we find that the [[ ]] does not infringe this dependent claim either.
34
The Remaining Asserted Patents
In H361933, the Branch found that STIIIZY met its burden of proof that the [[ ]]
does not infringe the asserted claims of the ’756, ‘757, and ’527 patents. H361933 at 41-45. We
adopt those same findings here and need not revisit them.
2. Summary of Infringement Findings
After reviewing the investigative record as well as submissions by both parties in this inter
partes proceeding and incorporating our findings in H361933, we conclude that STIIIZY has met
its burden of proof in establishing that its [[ ]] does not infringe the asserted claims of the
’756, ’757, ’527 and ’580 patents. STIIIZY has provided sufficient evidence establishing that the
[[ ]] does not practice the “vaporizer cartridge” limitation of claims 1 and 8 of the ’580
patent. Additionally, as we noted in H361933, STIIIZY has sufficiently shown that the
[[ ]] does not practice all the limitations of the ’756, ’757, and ’527 patents.
The following chart summarizes our infringement findings in regard to the [[ ]]:
Asserted Patents Asserted Claims Claims Claims
Not Infringed Infringed
U.S. Patent No. 11,369,756 1,5,10 1, 5, 10
U.S. Patent No. 11,369,757 1,13,15,20 1, 13, 15, 20
U.S. Patent No. 11,766,527 1,5,10-11,17-18, 1,5,10-11,17-18, 22
22
U.S. Patent No. 11,759,580 1,6-8,10 1, 6-8, 10
V. CERTIFICATION
Despite this ruling’s determination that the articles at issue are not subject to the 1392 LEO,
the EOE Branch acknowledges any concerns that PAX might have regarding the possibility of
circumvention. Thus, these concerns warrant conditioning entry for consumption of the articles at
issue into the United States on the drafting and submission of a certification pursuant to paragraph
4 of the 1392 LEO. According to the 1392 LEO, “[a]t the discretion of CBP and pursuant to the
procedures it establishes, persons seeking to import articles may be required to certify that they
are familiar with the terms of this Order, that they have made appropriate inquiry, and thereupon
state that, to the best of their knowledge and belief, the products being imported are not excluded
from entry under paragraph 1 of this Order. At its discretion, CBP may require persons who have
provided the certification described in this paragraph to furnish such records or analyses as are
necessary to substantiate the certification.” 1392 at ¶ 4.
Significantly, an importer’s ability to enter for consumption into the United States an article
addressed in a ruling under 19 C.F.R. Part 177 that resulted from an inter partes proceeding has
previously been conditioned by CBP to require a certification drafted with the participation of the
35
complainant. The EOE Branch previously explained the reasoning for this approach in HQ
H329187:
[I]n appropriate circumstances, the EOE Branch has conditioned an importer’s
ability to enter for consumption into the United States the article at issue according
to a ruling under 19 C.F.R. Part 177 that resulted from an inter partes
proceeding. See CBP Headquarters Ruling H324813 (dated June 3, 2022) at 47
(“Thus, it is CBP’s position that the articles at issue are subject to exclusion from
entry for consumption based on the 1191 LEO until Google: (1) disables or renders
inoperable the Device Utility app such that it can no longer be used with the articles
at issue and provide notice of this action or (2) establishes non-infringement for the
articles at issue pursuant to an ancillary proceeding at the Commission or an inter
partes proceeding requested from CBP under 19 C.F.R. Part 177 that addresses
operation of the Device Utility app on the articles at issue.”). Additionally, in
certain cases, the Intellectual Property Rights Branch (the predecessor to the EOE
Branch) treated the filing of a certification as a condition for entry following a
favorable ruling under 19 C.F.R. Part 177. See CBP Headquarters Ruling H282234
(dated May 16, 2017) at 9 (“Because there is currently no simple method to test
whether a particular GFCI utilizes three electrically isolated conductors without
disassembling the GFCI, we are requiring that Royal Pacific Corporation file a
certification upon ENTRY (along with any other required entry documents) for any
imported GFCIs certifying that said merchandize does not utilize three electrically
isolated conductors and thus does not satisfy the independent claim limitations of
the ’809 patent.”); see also CBP Headquarters Ruling H311351 (dated August 19,
2020) at 29 (“In addition, with each entry of the articles at issue, CBP will require
from persons importing the articles at issue (1) a certification, as approved by CBP;
and (2) upon request by CBP, to furnish such records or analyses necessary to
substantiate the certification.”) (internal citation omitted). Based on the concerns
raised by the potential to modify the articles at issue post-importation, we find that
the use of a certification as a condition of entry is appropriate.
Thus, the EOE Branch finds that conditioning the entry for consumption into the United States of
the articles at issue on the submission of a certification is appropriate.
VI. HOLDING
Having reviewed both parties’ arguments and the supporting evidence, we determine that
STIIIZY has met burden of proof in establishing that the [[ ]] does not infringe the asserted
claims of the asserted patents of the 1392 LEO. Accordingly, we hold that the [[ ]] is not
subject to the 1392 LEO.
This decision is limited to the specific facts set forth herein. If articles differ in any material
way from the articles at issue described above, or if future importations vary from the facts
stipulated to herein, this decision shall not be binding on CBP as provided for in 19 C.F.R. §§
177.2(b)(1), (2), (4), and 177.9(b)(1) and (2).
36
Sincerely,
Alaina van Horn
Chief, Exclusion Order Enforcement Branch
CC: Lyle Vander Schaaf
Crowell & Moring LLP
1001 Pennsylvania Avenue, NW
Washington, DC 200004
[email protected]
[email protected]
37